Transformer-Based Deep Learning Framework for Predicting Stimuli-Responsive Release Profiles in Nano-Drug Delivery Systems

Venkateswaran Govindarajulu, Lokesh K · Dr. Yashwant Research Labs Pvt. Ltd. · 2026

A Transformer-based deep learning framework predicts drug release profiles from stimuli-responsive nanocarriers with high accuracy.

High AI ConfidenceStrong SourceSimulationReadiness Unknown

Plain English summary

This study presents a new deep learning framework that uses Transformer architecture to predict how drugs are released from stimuli-responsive nanocarriers. These nanocarriers respond to environmental changes like pH and temperature, which can affect drug delivery effectiveness.

Why this matters

Accurate predictions of drug release profiles can significantly enhance the design of drug delivery systems, making treatments more effective. This research could lead to better patient outcomes by optimizing how and when drugs are released in the body.

Key findings

  • Introduced a Transformer-based framework for predicting drug release kinetics.
  • Achieved an R² score of 0.941 and a mean absolute error of 0.082.
  • Outperformed traditional models like LSTM and GNNs.
  • Utilized a dataset of eight different drugs across various responsive systems.
  • Demonstrated potential for integration into clinical decision support.

What's new

The use of Transformer architecture for predicting drug release kinetics in stimuli-responsive systems is a novel approach that captures complex interactions better than previous models.

Limitations

The abstract does not discuss the limitations of the dataset or the generalizability of the model to other drug types or delivery systems.

Commercial context

The abstract does not provide information on commercial applications or readiness.

Publication

Publisher
Dr. Yashwant Research Labs Pvt. Ltd.
Publication date
May 30, 2026
Research type
Paper

Tags

More on Stimuli-Responsive Materials

See all →
Stimuli-Responsive Materialspaper· Jun 17, 2026

Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges

Stimuli-responsive nanocarriers are advanced systems designed to release drugs in response to specific biological or external signals, enhancing targeted drug delivery.

Lakshmikanta Lakshmikanta, Vaishalli Vaishalli +4 · Dr. Yashwant Research Labs Pvt. Ltd.Concept
Stimuli-Responsive Materialspaper· May 25, 2026

Smart Stimuli-responsive Nanocarriers in Nanotechnology-based Cancer Diagnosis and Treatment

Smart stimuli-responsive nanocarriers enhance cancer treatment by enabling targeted drug delivery and reducing side effects.

Soham Joshi, Ganesh Muleva +3 · Bentham Science Publishers Ltd.Unknown
Stimuli-Responsive Materialspaper· May 5, 2026

Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: A Review

Smart nanocarriers enhance targeted drug delivery by responding to specific stimuli, improving therapeutic efficacy while minimizing side effects.

Vishal H. Thorat, Shagufta J. Pathan +4 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Stimuli-Responsive Materialsarticle· May 5, 2026

Next Generation of Drug Delivery: Stimuli Responsive Drug Delivery Overview

Smart drug delivery systems enhance therapeutic effectiveness by providing controlled and targeted drug release in response to specific stimuli.

Harshada T. Nanaware, Vikrant N. Patil +5 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Stimuli-Responsive Materialsnews· Apr 16, 2026

Light-activated gel could impact wearables, soft robotics, and more

A light-activated, biocompatible soft gel is reported to dramatically change its conductivity, supporting ionotronics-style interfaces for wearables and soft robotics.

· MIT News — MaterialsUnknown
Stimuli-Responsive Materialspaper· Apr 13, 2026

Stimuli-Responsive Drug Delivery Platforms Design Strategies and Therapeutic Applications

This research explores advanced stimuli-responsive drug delivery systems that enhance targeted therapy and precision medicine.

Dr Ranadheer Donthi, Andrea Varghese +4 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Method note: Summaries and ratings on this page are generated by AI from the abstract only. Read the original paper for full context. · Model: gpt-4o-mini-2024-07-18